Cognitive Behavioral Psychotherapy as an Add-on in Comprehensive Outpatient Care of Non-affective Psychoses: A Multicenter Randomized-Controlled Effectiveness Trial in a Naturalistic Setting
Authors:
- 14 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 51 (3) , 742-753
Abstract
Background and Hypothesis: Non-affective psychoses (NAP) are associated with severe consequences with regard to social functioning, physical health, employment, and suicidality. Treatment guidelines recommend cognitive behavioral therapy for psychosis (CBTp) as an effective additional treatment strategy to psychopharmacology. We hypothesized that outpatient CBTp has an add-on effect in individuals with NAP who already receive comprehensive outpatient care (COC) in Germany. Study Design: In a randomized-controlled effectiveness trial, 6 months of COC + CBTp were compared to COC. The primary outcomes were change of symptom severity as assessed by the Positive and Negative Symptom Scale (pre-/post-treatment and 6-month follow-up). Mixed linear models and effect sizes were used to compare changes across treatment groups. Additionally, the number of readmissions was compared. Study Results: N = 130 individuals with chronic NAP were recruited (COC + CBTp: n = 64, COC: n = 66). COC + CBTp participants significantly improved more regarding positive symptom severity (estimated mean difference at follow-up: −2.33, 95% CI: −4.04 to −0.61, P = .0083, d = 0.32) and general psychopathology (estimated mean difference at follow-up: −4.55, 95% CI: −7.30 to −1.81, P = .0013, d = 0.44) than the COC group. In both groups, negative symptom severity did not change significantly over time nor did groups differ regarding readmissions. Conclusion: The results underline an add-on benefit of CBTp in chronically ill individuals with NAP. Superiority of CBTp was demonstrated in comparison with high-quality comprehensive care and may also be true in different comprehensive care settings. Clinical Trials Registration: DRKS00015627.Keywords
Funding Information
- Akademie Psychiatrie und Psychotherapie Ostwestfalen-Lippe
This publication has 28 references indexed in Scilit:
- SchizophreniaThe Lancet, 2022
- CBT for schizophrenia: a critical viewpointPsychological Medicine, 2019
- Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysisPsychopharmacology, 2018
- Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta‐analysisWorld Psychiatry, 2018
- Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysisThe Lancet Psychiatry, 2017
- What is the minimal dose of cognitive behavior therapy for psychosis? An approximation using repeated assessments over 45 sessionsEuropean Psychiatry, 2016
- An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidenceSchizophrenia Research, 2014
- Who stays, who benefits? Predicting dropout and change in cognitive behaviour therapy for psychosisPsychiatry Research, 2014
- Moving from efficacy to effectiveness in cognitive behavioral therapy for psychosis: A randomized clinical practice trial.Journal of Consulting and Clinical Psychology, 2012
- Validierung einer deutschen Version der Self-Compassion Scale (SCS-D)Zeitschrift für Klinische Psychologie und Psychotherapie, 2011